FibroPlant LNG IUS
Alternative Name: Fibroplant LNG14 (also LNG 20)
Description: A frameless LNG IUS releasing 14 mcg, or 20 mcg, of LNG/day for contraception. Anchoring technology affixes the device to the endometrium.
Product Details
User: Female
Hormonal: Yes
Delivery Method: Intrauterine
Duration Type: Long-acting
Duration: 3-5 years
Dose: 14 or 20 μg per day
Active Pharmaceutical Ingredient (API): - levonorgestrel
- levonorgestrel
Multipurpose Preventive Technology (MPT): No
Status Details
Developer: Contrel Research, Belgium
Project Phase: Limited Market Availability
Development Stage: Regulatory
Active Development: Yes
Status Details: - Review suggests product could have significantly reduced side effects profile due to its frameless design.
- Review suggests product could have significantly reduced side effects profile due to its frameless design.
Additional Information
References: Wildemeersch D., Andrade A., Goldstuck N.D., Hasskamp T., Jackers G. (2017) Intrauterine levonorgestrel delivery with frameless fibrous delivery system: Review of clinical experience. Int. J. Womens Health. 2017;21:49–58
Andrade A, Wildemeersch D. (2008) Menstrual blood loss in women using the frameless FibroPlant LNG-IUS. Contraception. 79(2):134-8.
Wildemeersch D. (2007) New frameless and framed intrauterine devices and systems: An overview. Contraception. 75(6 Suppl):S82-92.
Wildemeersch D., Andrade A., Goldstuck N.D., Hasskamp T., Jackers G. (2017) Intrauterine levonorgestrel delivery with frameless fibrous delivery system: Review of clinical experience. Int. J. Womens Health. 2017;21:49–58
Andrade A, Wildemeersch D. (2008) Menstrual blood loss in women using the frameless FibroPlant LNG-IUS. Contraception. 79(2):134-8.
Wildemeersch D. (2007) New frameless and framed intrauterine devices and systems: An overview. Contraception. 75(6 Suppl):S82-92.